一例發生強直持續狀態成年Lennox-Gastaut綜合征患者的治療體會_Journal of Epilepsy

Authors：

張淑靜 ¹ , 張培松 ² ,  柳琳 ¹ , 陳研修 ¹

1. ;
2. ;

Corresponding?author：

柳琳, Email: liulin.8025@163.com

Keywords：

強直持續狀態; 持續腦電監測; 爆發-抑制圖形

DOI：

10.7507/2096-0247.202305005

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 張淑靜, 張培松, 柳琳, 陳研修. 一例發生強直持續狀態成年Lennox-Gastaut綜合征患者的治療體會. Journal of Epilepsy, 2023, 9(5): 443-446. doi: 10.7507/2096-0247.202305005 Copy

1.	中國抗癲癇協會創新與轉化專委會. Lennox-Gastaut綜合征診斷治療的中國專家共識. 癲癇雜志, 2022, 8(3): 187-195.
2.	Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus—Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 2015, 56(10): 15-23.
3.	Samhitha Rai, Frank W Drislane. Treatment of refractory and super-refractory status epilepticus. Neurotherapeutics, 2018, 15(6): 697-712.
4.	Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain, 2012, 135(23): 14-28.
5.	劉曉燕、吳遜. 臨床腦電圖學, 人民衛生出版社, 2017: 321-324.
6.	Delaj L, Novy J, Ryvlin P. Refractory and super-refractory status epilepticus in adult: a 9-year cohort study. Acta Neurologica Scandinavica, 2017, 135(1): 92-97.
7.	Arayakarnkul P, Chomtho K. Treatment options in pediatric super-refractory status epilepticus. Brain Dev, 2019, 41(4): 359-366.
8.	齊霜, 鄭舒暢, 余建東, 等. 抗癲癇藥物加重癲癇發作的現狀及機制研究進展. 中華神經醫學雜志, 2019, 18(7): 745-749.
9.	Samanta D, Garrity L, Arya R. Refractory and super-refractory status epileptics. Indian Pediatrics, 2020, 57(3): 239-253.
10.	An J, Jonnalagadda D, Moura VJ, et al. Variability in pharmacologically-induced coma for treatment of refractory status epilepticus. PLoS One, 2018, 13(20): 83-89.

1. 中國抗癲癇協會創新與轉化專委會. Lennox-Gastaut綜合征診斷治療的中國專家共識. 癲癇雜志, 2022, 8(3): 187-195.
2. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus—Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 2015, 56(10): 15-23.
3. Samhitha Rai, Frank W Drislane. Treatment of refractory and super-refractory status epilepticus. Neurotherapeutics, 2018, 15(6): 697-712.
4. Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain, 2012, 135(23): 14-28.
5. 劉曉燕、吳遜. 臨床腦電圖學, 人民衛生出版社, 2017: 321-324.
6. Delaj L, Novy J, Ryvlin P. Refractory and super-refractory status epilepticus in adult: a 9-year cohort study. Acta Neurologica Scandinavica, 2017, 135(1): 92-97.
7. Arayakarnkul P, Chomtho K. Treatment options in pediatric super-refractory status epilepticus. Brain Dev, 2019, 41(4): 359-366.
8. 齊霜, 鄭舒暢, 余建東, 等. 抗癲癇藥物加重癲癇發作的現狀及機制研究進展. 中華神經醫學雜志, 2019, 18(7): 745-749.
9. Samanta D, Garrity L, Arya R. Refractory and super-refractory status epileptics. Indian Pediatrics, 2020, 57(3): 239-253.
10. An J, Jonnalagadda D, Moura VJ, et al. Variability in pharmacologically-induced coma for treatment of refractory status epilepticus. PLoS One, 2018, 13(20): 83-89.

Previous Article
DNM1基因變異所致發育性癲癇性腦病一例
Next Article
生酮飲食治療RHOBTB2基因相關發育性癲癇性腦病一例并文獻復習

Journal of Epilepsy

一例發生強直持續狀態成年Lennox-Gastaut綜合征患者的治療體會

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content